Eli Lilly Rises As Study Shows Omvoh Successful in Treating Crohn's Disease

Key TakeawaysEli Lilly reported its current treatment for ulcerative colitis, Omvoh, was effective in helping those with Crohn's disease.The Phase 3 trial showed more than half of those taking Omvoh achieved clinical remission in a year.Eli Lilly shares headed toward an all-time closing high on the news. Shares of Eli Lilly (LLY) were on track to close at an all-time high Tuesday as a study showed the pharmaceutical giant’s current drug for ulcerative colitis also was successful in treating Crohn’s disease. ...